The article was incredibly unspecific. No mention if the data from that site ended up being used. No mention that there were multiple sites run by multiple comp

The article was incredibly unspecific. No mention if the data from that site ended up being used. No mention that there were multiple sites run by multiple companies doing the testing, which is normal. What stage trials were these? Again, no mention. This is b.s. fearmongering, as if sharps in the wrong bin means the drug was not tested for efficacy or safety. I lived with someone project managing a failed pharmaceutical testing run. They throw the data out and use the accurate data from the many other sites. Or do the trials over. It happens. It wastes lots of money but it is no big deal in the grand scheme of things and certainly does not mean the drug is approved without adequate safety and efficacy testing.